Skip to main content
. 2021 Jul 29;8:689084. doi: 10.3389/fnut.2021.689084

Table 7.

Summary of the comparative analysis of the intervention studies included in this review.

Food N studies Subjects Study design Intervention Food intake evaluation Probiotic amount Cohort dimension Sequencing strategy Colonization Recurrent gut microbial groups mainly affected Bacteria able to colonize
Healthy Diseased Children Elderly Randomized Before/after Cross-over Duration CFU/day Large studies N > 40 Pilot studies N < 40 NGS Other Species-level Strain-level Viability Persistence
Probiotics Traditional 11 6 5 0 0 6 3 2 5 days-24 weeks 5 nd 5 6 7 4 2 1 1 1 Increased Lactobacillus
(n = 2)
B. mongoliense BMONG18, P. acidilactici, Staphylococcus, Lc. lactis, Leuc. mesenteroides
LcS 13 5 2 3 3 7 5 1 2–24 weeks 2 6.5 × 109-1 × 1011 6 7 4 9 0 8 3 6 Increased Lactobacillus
(n= 4) and Bifidobacteria
(n = 5). Decreased Enterobacteriaceae
(n = 4)
LcS
Other Lactobacilli 9 7 1 1 0 3 4 2 1–10 weeks 0 1 × 108-1 × 1011 1 8 3 6 5 4 3 7 Increased Lactobacillus or LAB
(n = 6). Bifidobacterium divergent results
(n = 3)
La. paracasei subsp. paracasei CNCM I-1518; L a. paracasei subsp. paracasei CNCM I-3689; L a. rhamnosus CNCM I-3690; L. johnsonii 456; L. johnsonii La1; LGG; L a. casei DN-114 001; L a. paracasei A
Bifidobacterium 12 6 5 0 1 6 4 2 1–8 weeks 2 1 × 108-1 × 1010 3 9 6 6 4 1 1 4 Increased Bifidobacterium
(n = 7)
B. animalis subsp. lactis; B. animalis subsp. lactis CNCM I-2494; B. animalis subsp. lactis DN-173 010 (CNCM I-2494)
Synbiotics 5 4 1 0 0 4 1 0 3–12 weeks 1 2 × 107-1 × 1011 1 4 2 3 0 2 1 2 Divergent results L. acidophilus La-5; B. animalis subsp. lactis BB-12; LGG
Total 50 28 14 4 4 26 17 7 10 16 34 22 28 11 16 9 20
a

Recently renamed Lacticaseibacillus.